Cardiac biosensors stand at the forefront of transformative healthcare technologies, revolutionizing the landscape of cardiovascular diagnostics and monitoring. These state-of-the-art biosensors employ sophisticated sensing mechanisms to identify specific biomarkers or physiological signals associated with cardiac health. The real-time and precise data provided by cardiac biosensors enable healthcare practitioners to make informed decisions promptly, ushering in a new era of personalized and responsive patient care. These biosensors are instrumental in the early identification, continuous monitoring, and effective management of cardiovascular conditions, significantly enhancing patient outcomes. As the field of biosensing technology evolves through ongoing research and development, the incorporation of cardiac biosensors promises to redefine the standards of cardiovascular healthcare, bringing forth a future where proactive and personalized cardiac monitoring becomes integral to the standard of care.
Title : Revolutionizing CKD care: How finerenone transforms outcomes in heart and kidney health - Insights from fidelio-DKD
Robert J Chilton, University of Texas Health Science Center San Antonio, United States
Title : Novel important cellular responses, signaling mechanisms and therapeutic options for pulmonary hypertension and right heart failure
Yong Xiao Wang, Albany Medical Center, United States
Title : Preventing sports-related cardiac arrest: Coronary artery calcium scoring stratifies the benefit of low-dose aspirin use for risk reduction
Arthur J Siegel, Massachusetts General Hospital, United States
Title : Empathy and precision: Revolutionizing communication between cardiologists and patients
Iris Panagiota Efthymiou, University of Greenwich, United Kingdom
Title : Post-cardiotomy ECMO (PC-ECMO)
Gustavo Lionel Knop, Mayo Clinic, United States
Title : The past, present and future of AI in cardiology
Narendra Kumar, HeartbeatsZ Academy, United Kingdom